Shafabakhsh R, Mobini M, Raygan F, Aghadavod E, Ostadmohammadi V, Amirani E, et al
They highlight promising candidates for further testing, bridging computational predictions and therapeutic development
Achieving long-lasting, transformative results requires more than just one treatment
In patients with low-grade gliomas and patients with secondary glioblastoma, the proportion of IDH1 mutations can reach about 70%, but there is currently no selective treatment for IDH1 mutant gliomas
A nutrient-packed moisturizer with a rich, velvety texture that deeply moisturizes yet absorbs quickly without any residual grease or stickiness
Today, more than 100,000 happy customers in Pakistan serve as living proof of how effective the approach taken by the company is